Pneumococcal conjugate vaccines in different settings - Authors' reply

Lancet Infect Dis. 2019 Dec;19(12):1284. doi: 10.1016/S1473-3099(19)30630-9.

Authors

William P Hanage¹, Joseph A Lewnard²

Affiliations

¹ Center for Communicable Disease Dynamics, Harvard TH Chan School of Public Health, Boston, MA, USA.
² Division of Epidemiology, School of Public Health, University of California, Berkeley, CA 94720, USA. Electronic address: jlewnard@berkeley.edu.

PMID: 31782391
DOI: 10.1016/S1473-3099(19)30630-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Pneumococcal Infections*
Pneumococcal Vaccines*
Serogroup
Vaccines, Conjugate

Substances

Pneumococcal Vaccines
Vaccines, Conjugate